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The split structure of most mammalian protein-coding genes allows for the potential to produce multiple different
mRNA and protein isoforms from a single gene locus through the process of alternative splicing (AS). We propose a
computational approach called UNCOVER based on a pair hidden Markov model to discover conserved coding exonic
sequences subject to AS that have so far gone undetected. Applying UNCOVER to orthologous introns of known human
and mouse genes predicts skipped exons or retained introns present in both species, while discriminating them from
conserved noncoding sequences. The accuracy of the model is evaluated on a curated set of genes with known
conserved AS events. The prediction of skipped exons in the ;1% of the human genome represented by the ENCODE
regions leads to more than 50 new exon candidates. Five novel predicted AS exons were validated by RT-PCR and
sequencing analysis of 15 introns with strong UNCOVER predictions and lacking EST evidence. These results imply that
a considerable number of conserved exonic sequences and associated isoforms are still completely missing from the
current annotation of known genes. UNCOVER also identifies a small number of candidates for conserved intron
retention.
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Introduction
Almost all protein-coding genes of humans and other
mammals have a split structure with several exons and
introns. Intronic sequences are removed from the primary
transcript by the process of pre-mRNA splicing [1], an
essential step in eukaryotic gene expression. The number of
functional variants generated from one transcript can be
greatly increased by alternative splicing (AS), in which one or
more exons or parts thereof are skipped, or an intron is
retained, when compared to a different transcript from the
same gene [2–4]. By this mechanism, an organism can
generate several protein isoforms from a single gene,
potentially leading to huge numbers of protein variants,
and AS is an important means of gene regulation, being
frequently used during development or in differentiation. It
is also a very common event: even conservative estimates put
the fraction of human genes with more than one isoform at
40% [5], with similar rates estimated in all animals [6]. The
basic types of AS are exon skipping, intron retention, and
alternative 59 and 39 splice site usage, with exon skipping
being the most prevalent in mammals [7–10]. To date, AS
events have been identiﬁed on a large scale primarily from
comparisons and alignments of expressed sequence tag (EST)
and cDNA sequences, and databases based on these align-
ments have been described [8,10,11]. Ab initio prediction of
AS events from one genomic sequence alone has been
attempted only rarely: Computational screening of introns
for sequences similar to neighboring exons revealed candi-
date duplicated exons, which may be involved in mutually
exclusive splicing [12]. A hidden Markov model (HMM)
sampling approach can detect likely variants of complete
gene structures [13]. These studies, however, did not
experimentally verify predicted AS events.
Despite the large number of ESTs that have been
sequenced from a variety of organisms and tissues, the
coverage of the transcriptome still remains limited, especially
for genes expressed at lower levels or under limited
conditions. It becomes increasingly hard to distinguish
functional but rare EST-detected variants from nonfunc-
tional isoforms and artifactual sequences contained in the
libraries [7]. At least in mammals, the less common isoforms
are often not conserved, in contrast to the high degree of
conservation seen for the more common variants [14,15].
Exons subject to nonconserved skipping events are signiﬁ-
cantly different from alternative conserved exons (ACEs,
pairs of orthologous human/mouse exons both subject to
exon skipping), being less likely to preserve reading frame
and more likely to contain in-frame stop codons, suggesting
that a signiﬁcant fraction does not lead to functional proteins
[3]. ACEs also tend to be ﬂanked by long, highly conserved
intronic sequences, possibly because of the presence of
sequence elements required to regulate inclusion of the
exons in speciﬁc cell types or conditions. Regions containing
ACEs are thus often among the most highly conserved
segments in the human genome [16,17]. Two non-EST-based
computational approaches have made use of these speciﬁc
features to successfully classify conserved exons as to whether
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that current coverage of splicing isoforms by ESTs alone is
still limited, but that most EST-derived skipping events may
in fact not be conserved. Regarding intron retention events
(IREs), a recent study estimated that they occur in about 15%
of human genes [19]; however, stricter requirements lower
this estimate to 5% [7,19], and half of these cases are within
the untranslated region and thus do not alter the encoded
protein. Only ten of the reliably determined IREs, coding or
noncoding, were found to be clearly conserved between
human and mouse, based on currently available EST and
cDNA evidence, suggesting that this mode of regulation is not
common in mammalian genes.
Results
Design of a Pair HMM to Discover Conserved AS
Given that conserved coding AS events have the potential
to alter protein isoforms under tightly regulated circum-
stances, these sequences should be among the functionally
most important segments of the genome. Computational
approaches to predict ACEs [17,18] demonstrated that
inferring AS events from ESTs alone will miss a considerable
fraction of conserved skipping events: those for which
current EST libraries contain only those isoforms that
include the exon. Presumably, this is caused by the fact that
the majority of isoforms include the ACE under consider-
ation. Here, we set out to develop a complementary approach
to predict those conserved AS events in which the majority of
isoforms do not include the ACE or retained intron, and for
which the exonic sequence subject to AS is thus completely
absent in available EST sequences and has not been described
before.
To systematically identify such previously unknown ACEs
and IREs missed by comparative gene-ﬁnding and cDNA and
EST alignments, we developed a system for comparative
prediction of mammalian conserved coding AS events termed
UNCOVER (for ‘‘unknown conserved variable exon recog-
nition’’). UNCOVER is based on a pair HMM (pHMM) [20–
22], a probabilistic model that can be used to obtain an
optimal alignment and simultaneous annotation of two
sequences. A pHMM consists of states that can be either pair
states, which contain a probability distribution on the
occurrence of pairs of aligned nucleotides, or single states,
which model nucleotides in one sequence but not the other,
thus describing insertions and deletions. Different states are
used to model different patterns of conservation, e.g., the
distribution in a state for the third codon position will
typically contain higher probabilities for mismatches than the
one for the ﬁrst or second position, and those mismatches not
changing the encoded amino acid will be more frequent than
others. While computing the optimal alignment, a pHMM
labels the alignment with the states that were used in the
process, and the aligned sequence can be parsed into
functional categories based on the labels.
The UNCOVER pHMM was designed to speciﬁcally align
one orthologous human/mouse intron pair at a time and to
predict whether it potentially harbors undiscovered AS
events (Figure 1). The model states describe the probability
of aligned nucleotide pairs in the 39 and 59 splice sites, coding
regions, and noncoding alignable regions, as well as single
nucleotides in nonalignable regions (i.e., insertions or
deletions in the human sequence when compared to mouse).
The transition probabilities of the model connect the states
in different ways corresponding to submodels for none or any
one of four basic AS events: skipping, retention, and
alternative 59 and 39 exons. A labeled UNCOVER alignment
can thus predict whether a conservation pattern seen in the
intron pair ﬁts better to conserved noncoding sequence, to
coding sequence throughout—suggesting intron retention—
or to the conserved sequence of f39 splice site, coding exon,
59 splice siteg somewhere within the intron pair, suggesting
the presence of an ACE (see Figure 1 for a detailed
description of the model, and Figure 2 for an example
alignment). The UNCOVER submodels for alternative 59 and
39 exons are at this point used only to achieve better
discrimination between the different AS types, and are not
analyzed in detail in this study.
Candidate structures scored by current ab initio gene-
ﬁnding algorithms are limited in that they have to fulﬁll the
restrictions of the whole gene model—including presence of
an open reading frame throughout and distributions on the
expected length of exons. The UNCOVER model as shown
does not impose these restrictions and thus has the potential
to detect conserved events missed by computational gene
ﬁnders. It can be used to predict new AS events in two species
simultaneously, or to provide additional evidence for a
conserved AS event in case of limited EST coverage or ESTs
from only one of two species. An advantage of our pHMM is
that, in addition to identifying AS events, it also identiﬁes
conserved noncoding sequences, potentially containing cis-
regulatory elements for splicing or transcription. UNCOVER
per se identiﬁes any kind of coding sequence ﬁtting the
pHMM model, which means that predicted skipped exons
may in fact simply be exons missed by the existing annotation
that are conserved but not alternatively spliced. In practice,
however, the pipeline to determine the input intronic regions
uses annotations of conserved gene structures, which are
generally inferred from EST and cDNA evidence, and by
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Synopsis
Alternative splicing is a process in which more than one protein
variant can be produced from one gene: Specific parts of the mRNA
precursor are included or excluded during the processing into the
mature transcript. It is very prevalent in mammalian genomes, and
variants are often specific for particular cell types, developmental
states, or environmental changes. The identification of such variants
has until recently relied solely on the sequencing and comparison of
expressed sequence tags (ESTs), but the number of available ESTs is
not large enough to cover all variants under all conditions.
Ohler et al. have now devised a comparative genomics algorithm
based on a pair hidden Markov model, which identifies parts of
genes that are alternatively spliced and have not been observed in
ESTs. Starting from known annotated genes conserved in human
and mouse, they scan corresponding intron pairs of these genes to
identify conserved sequences that match the model. Experimental
validation of a number of new predictions show that the approach
can successfully uncover splice variants that are as yet unknown and
not part of the large libraries of ESTs. Together with recently
proposed complementary computational methods, this approach
helps us to complete our knowledge about the transcript diversity
created by alternative splicing.deﬁnition most true positive predicted exons are thus
skipped exons.
Application of UNCOVER on a Curated Dataset of Known
Skipped Exons
To establish a baseline for how well ACEs can be detected
with our approach, we collected 241 orthologous introns
containing known ACEs derived from human and mouse EST
and cDNA alignments, ranging in length from about 250 nt to
about 93,000 nt. UNCOVER made a total of 309 predictions
with 210 true positives (Table 1), successfully pinpointing the
exact location of the ACEs: 89% of true positive UNCOVER
predictions identiﬁed at least one splice site exactly. The
inexactness of the remaining 11% reﬂected the strong
sequence conservation around ACEs, which makes it difﬁcult
to infer the exact location of the correct splice sites in some
cases. For comparison, we performed a simple BLASTN [23]
analysis, keeping all hits longer than 30 nt with E values
smaller than 10
 10. This resulted in 667 predictions, out of
which 253 overlapped with 233 known exons. However, not a
single hit corresponded to the exact exon boundaries.
BLASTN can thus detect the rough locations of the great
majority of ACEs in this set, but in an extremely unspeciﬁc
manner; using TBLASTX instead of BLASTN gave highly
similar results. Retaining only the best hit with at least 70%
sequence identity but independent of E value resulted in 212
hits (88%) overlapping ACEs. The UNCOVER detection rate
is thus virtually identical to the best BLAST hit analysis, but
without making any unrealistic assumptions as to whether or
how many ACEs may be present in an intron (and,
importantly, UNCOVER predictions usually have one or
both splice sites correct).
As an alternative to probabilistic sequence models, the Ka/
Ks test has recently been applied to the problem of
comparative gene ﬁnding. This is an established method to
detect adaptive molecular evolution, based on the observa-
tion that coding sequences are generally under selection to
conserve amino acid sequence. In an application of the Ka/Ks
test to gene ﬁnding [24], 92% of internal exons passed the test
at a p-value of 0.05. However, only 47% of the tested
conserved skipped exons in our set of 241 exons passed the
test at the same p-value, even under the assumption of
knowing the exact exon boundaries. This is apparently due to
the smaller size of the skipped exons (median 84 nt compared
to 123 nt in the set of constitutive exons used in [24]) and the
higher rate of synonymous sequence conservation of ACEs
compared to constitutive exons (see Protocol S1 for details).
The Ka/Ks test therefore has inherent limitations when
applied to detect alternatively spliced exons.
Analysis of the ENCODE Target Regions
As an application of UNCOVER on a genomic scale, we
focused on the 1% subset of the human genome known as the
ENCODE (Encyclopedia of DNA Elements) target regions,
currently the subject of comprehensive experimental and
computational analyses [25]. UNCOVER made 135 predic-
tions in 73 out of a total of 1,776 orthologous introns (4.1%),
located in 40 out of 323 genes (12.4%). In comparison, there
were 982 BLAST hits to 321 introns with the thresholds set as
above, more than seven times as many hits at a similar level of
sensitivity. A total of 42 UNCOVER predictions corre-
sponded to either annotated human skipped exons or
sequences covered by human ESTs in dbEST (as of August
23, 2004): 15 matched annotated ACEs in known Ensembl
genes; seven matched annotated Ensembl EST genes or VEGA
(the manually curated Vertebrate Genome Annotation data-
base [26]; http://vega.sanger.ac.uk) genes; and three matched
spliced ESTs not corresponding to any annotation, indicating
the presence of yet unannotated ACEs in the genes LUC7L,
C16orf35, and CDH2. The remaining predictions matched
unspliced ESTs corresponding to 11 intronic regions. Many
of these ESTs were polyadenylated, and one of the matches
was annotated as an alternative terminal exon of an EST
gene. Indeed, we observed that with only one exception, these
UNCOVER predictions were located in the 39 terminal region
of the genes. The location of these putative terminal exons
cannot be expected to be exactly predicted by UNCOVER, as
they do not end with a 59 splice site and contain 39
untranslated sequence.
For experimental validation, we selected those 20 introns
containing predicted ACEs without any EST evidence that
were ﬂanked on both sides by strong splice sites. We followed
an RT-PCR sequencing protocol in a set of eight adult human
tissues and HeLa cells, and conﬁrmed expression of the
ﬂanking exons for 15 out of the 20 tested introns (i.e., in ﬁve
cases, we could not observe any expression in the selected
tissues using multiple sets of primers). For ﬁve out of these 15,
we repeatedly observed two PCR bands, with the sequence of
the smaller product matching the exons ﬂanking the
predictions, and in one additional case, we saw expression
of a product using primers placed inside the predicted ACE
and a neighboring exon. In three of these six cases (including
the gene ST7), the sequence of the alternative product
included the UNCOVER predicted exons, showing that our
approach led to the discovery of new ACEs expressed at low
levels that had not yet been covered despite the availability of
more than 5 million human ESTs (Figure 2; see also Dataset
S1 for details). One case (CRAT) corresponded to a skipped
exon in which only a small part in the middle was conserved
between human and mouse, and which could therefore not be
predicted by UNCOVER. In the remaining two cases
(including MCF2L), the included alternative sequence did
not match any sequence in the nonredundant GenBank
database, suggesting gaps or misassemblies in these introns.
Furthermore, we conﬁrmed two of the ten potential new
alternative terminal exons, using primers placed inside the
predicted exon and the immediately upstream exon. Not
counting the cases with nonmatching sequence, we therefore
report here eight conserved AS events—ﬁve veriﬁed by RT-
PCR based on de novo predictions plus three with spliced
EST evidence—in addition to 15 known events present in the
Ensembl annotation of the ENCODE regions (as of August
2004), and provide additional support for eight more ACEs
that have only been annotated as part of Ensembl EST genes
or cross-species homology.
A Genome-Wide Search for Conserved Retained Introns
Turning to conserved intron retention, we extended the
UNCOVER analysis to the whole genome. Our analysis
spanned a total of 84,233 orthologous intron pairs, 46 times
the number within the ENCODE region, which covers 1% of
the nucleotides in the genome but is somewhat gene rich.
Despite this large number of introns, and without assump-
tions on the reading frame of the upstream exon, only 23
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Discovering Unknown Alternative ExonsFigure 1. Structure of the UNCOVER pHMM
The model is used to globally align a pair of orthologous human/mouse introns and detect conserved coding AS events.
(A) A schematic overview of the model architecture, with circles indicating groups of functionally related states. For accurate splicing, the two ends of
an intron must be precisely determined by the splicing machinery. The prominent sites for this process are the 59 splice site (59ss) at the junction
between the upstream exon and the intron and the 39 splice site (39ss) at the junction of the intron and the downstream exon. As reference,
pictograms of the mammalian 59 splice site and 39 splice site are depicted, in which the letters at individual positions are scaled according to their
frequency. We restrict ourselves to U2-type splice sites with perfectly conserved GT–AG dinucleotides. The alignment always starts with the conserved
59 splice site after the initial GT dinucleotide. The transitions of the model then allow it to pursue several paths, corresponding to different types of AS,
indicated by small icons. (1) The ‘‘default’’ is to observe conserved or nonconserved noncoding sequence, possibly alternating between these two. (2)
Transitions to an ACE sequence of conserved f39 splice site, skipped exon, 59 splice siteg are possible at any time, and can also occur more than once.
(3) An IRE is modeled by going from a 59 splice site to a 39 splice site by only passing through a coding submodel. (4) and (5) An early exit from this
codon model through another 59 splice site leads to an alternative 59 exon at the beginning of the sequence, or correspondingly to an alternative 39
exon at the end. The alignment is fixed on the right side by the 39 splice site at the end of the intron. All splice site states are first-order pair states not
allowing for insertions or deletions. The 59 splice site part of the model covers 9 nt (3 nt in the exon, plus the conserved GT and the following 4 nt in
the intron); the 39 splice site is 23 nt long (18 nt and the conserved AG in the intron plus 3 nt in the exon).
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coding potential than to harbor conserved noncoding
sequence (see Table 2 and Dataset S2). Out of these, 12 were
covered by human ESTs (as of October 25, 2004), with a total
of ten annotated as known or EST genes. The length of 12
candidates was a multiple of three, and 13 out of 19 for which
we could determine the open reading frame from full-length
cDNAs were predicted to continue in the frame of the
upstream exon. Given evidence of length, reading frame, EST
coverage, and the presence of protein domains spanning the
candidate IRE, another four (among them PAX6 and PCDH17)
in addition to the ten already annotated can be considered
highly likely IREs, and an additional two involve splicing of an
alternative 59 splice site in a mutually exclusive fashion to one
of the neighboring exons.
Discussion
We propose a comparative sequence analysis approach to
detect hitherto unknown and alternatively spliced conserved
exons, followed by experimental validation. Considering the
53 introns with UNCOVER predictions in the ENCODE
region that do not contain annotated skipped exons, and
adjusting the number by the sensitivity (87%) and speciﬁcity
(68%) of UNCOVER on the curated ACE dataset, leads to an
estimated total of 53(0.68)/(0.87) ¼ 41 ENCODE introns
containing ACEs not currently annotated. This shows that
even for known and well-studied genes, current EST coverage
is far from providing a complete picture of AS. Scaled up to
the whole genome, which contains 46 times the number of
introns in the ENCODE region, about 1,900 introns may
harbor as yet unknown ACEs. Since speciﬁcity may be
overestimated somewhat using the curated ACE dataset, as
a lower estimate, a straight extrapolation of the so far
experimentally veriﬁed ACEs suggests that at least several
hundred ACEs are currently still awaiting discovery. We
expect that UNCOVER will therefore be especially useful
when turning to regions of the genome less covered by ESTs
[27] than the ENCODE targets. On the other hand, retention
of translatable introns does not appear to play a major role in
generating conserved protein-coding isoforms in mammals.
We do not rule out a common role for nonconserved
regulated intron retention or conserved IREs in UTRs or in
species other than mammals.
Considering the RT-PCR results, the isoforms that include
the newly veriﬁed exons are expressed at lower levels than the
isoforms in which the exons are skipped. This is in
accordance with the lack of support in EST data: were the
isoform with the exon included the major one, we would
expect it to have been observed in the EST data. Detailed
measurements of the frequency of individual AS events, such
as for the well-studied cell-surface receptor CD44, showed
that the inclusion of functional alternatively spliced exons
can indeed be much less common than skipping [28]. A
number of points argue for the functional relevance of our
newly detected minor isoforms: we are usually able to amplify
them by placing primers in the ﬂanking exons (see Figure 2);
they are expressed in a tissue-speciﬁc manner in human, and
we observe expression in mouse as well (Figure S1); and their
sequence is conserved not only in mouse but in a number of
other vertebrate species (see Dataset S1).
In its current state, UNCOVER is designed to predict only
fully coding exons. In addition to an easy adaptation to pairs
of non-mammalian species such as nematodes or insects,
further development of UNCOVER could lead to removal of
this restriction to include exons with in-frame stop codons
and noncoding 39 ends. This should enable us to better
predict terminal exons that are only partly coding: we showed
that these can be predicted by the current version of
UNCOVER, but an explicit model of noncoding conservation
and polyadenylation sites would undoubtedly lead to im-
provements. Furthermore, including in-frame stop codons
may allow predictions of additional ACEs subject to non-
sense-mediated decay (NMD), a mechanism that degrades
transcripts containing premature termination codons [29].
NMD has been proposed as an important mechanism for gene
regulation in conjunction with AS [9]. A PCR veriﬁcation of
predictions subject to NMD could be done following knock-
down of the important enzymes in the NMD pathway, to be
able to accumulate and amplify the transcripts. To gain
additional conﬁdence in such predictions, UNCOVER ought
to be extended to more than two species, which should
additionally allow reliable prediction of alternative 59 and 39
splicing that may lead to isoforms differing by only a few
nucleotides. This can be done in a way similar to an approach
based on probabilistic phylogenetic models [30].
Recent independent methods based on comparative
genome analysis [17,18,31], which can be regarded as
complementary to the work described here, have been
successful in classifying known conserved exons as skipped
or constitutive. These approaches are based on methodology
from statistical learning theory, and a true integration with a
probabilistic approach such as UNCOVER is not straightfor-
ward. However, they could be easily used to ﬁlter our
predictions. A genome-wide veriﬁcation of such predictions
is planned, which should contribute to completing our
picture of the extent and prevalence of conserved AS.
Materials and Methods
Training and test datasets. A comprehensive set of reliably
annotated exon–intron structures of mammalian genes, including
information about alternative structures as well as conservation in
multiple species, was a crucial starting point for our research. The
gene annotation system GENOA is a suite of programs for the spliced
alignment of sets of mRNA sequences and ESTs against a whole
genome and was used to align human and mouse ESTs and cDNA
sequences (described in more detail elsewhere [32]). GENOA detects
matches between a repeat-masked cDNA sequence and genomic DNA
using BLASTN and maps the original cDNA to the assembled human
genome using the spliced alignment algorithm mRNAvsGen. Sub-
(B and C) A detailed view of the noncoding intronic submodel (B) and a close-up of the coding submodel (C), with closed circles representing pair states
and dashed circles representing single states. Thick straight arrows indicate the allowed start and end states of the submodels. The noncoding
conservation (B) is modeled by a first-order pair state, allowing insertions and deletions of individual nucleotides. The null model contains single first-
order states representing nonconserved human and mouse intronic sequences. The coding states (C) comprise three second-order pair states for
nucleotides in the three codon positions, as well as three second-order single states each for human and mouse to capture species-specific codon
insertion/deletion events. The transition matrix ensures that only those insertion/deletion events covering complete codons are admissible.
DOI: 10.1371/journal.pcbi.0010015.g001
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(A) RT-PCR validation of newly identified alternative exons with no prior EST evidence. Lane numbers are given in Arabic numerals below the gel;
sample numbers of new verifications and negative controls are in Roman numerals above. Lanes 2–5 were verified using flanking primers and therefore
show two bands each, the larger one corresponding to the event including the newly identified ACE. Lanes 6–9 used a primer internal to the newly
identified exon and therefore only show one band each. Lanes 10–13 are typical examples of ten randomly selected introns in the ENCODE target
regions that were not predicted to harbor AS events. Lane 14 shows a blank reaction control without adding template. Lanes 1 and 15 contain size
markers spaced at 100 nt intervals, with the strong bands corresponding to 1,000 and 500 nt. Ensembl ID pairs for the known exon upstream of the
validated new one and the corresponding gene are as follows: internal exons, lanes 2–6: ENSE00000881911.1:ENSG00000004866.5,
ENSE00000862512.1:ENSG00000126217.3, ENSE00001201432.1:ENSG00000168781.5, ENSE00001146476.1:ENSG00000168781.5, and EN-
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cDNA sequence and EST sequences and maps ESTs to regions with
cDNA-aligned genomic DNA using SIM4 [33] to ensure a high quality
of annotation. SIM4 aligns ESTs with genomic sequences containing
the cognate genes, allowing for introns in the genomic DNA sequence
and a relatively small number of sequencing errors.
We obtained chromosome assemblies (hg13) of the human genome
from the University of California at Santa Cruz Web server (http://
genome.ucsc.edu), transcript data in the form of about 94,000 human
cDNA sequences from the combined GenBank ﬁles of gpri and gbhtc
(release 134), and human ESTs from the database dbEST in
repository 032703. Overall, GENOA aligned about 86,000 cDNAs
and 890,000 ESTs, which resulted in about 20,800 gene regions within
the human genome that exhibited multi-exon structures. The
relatively low number of alignments was due to enforcement of
stringent alignment criteria. Only ESTs that had at least partial
overlap with a cDNA were aligned to the genome, and only those
alignments that spanned at least one intron and that met stringent
coverage (.90%) and identity levels (.90%) were considered. In the
same manner, GENOA was applied to the mouse genome, taking
version 3 of the assembly and the same releases of GenBank and
dbEST as above. With the same criteria as used for the human data,
we successfully aligned about 19,000 cDNAs and 480,000 ESTs,
leading to 14,800 gene regions.
For candidate gene regions with alternative exon–intron struc-
tures, the spliced alignments were compared for each exon.
Annotated 59 terminal and 39 terminal exons were separated from
internal exons and excluded from further analysis. Internal exons
were classiﬁed as constitutive, alternative 39 splice site, alternative 59
splice site, skipped, overlapping, and containing retained introns.
With these alignments and the annotation of orthologs from Ensembl
[34], we determined orthologous gene pairs containing conserved AS
events. Applying stringent quality ﬁlters, we identiﬁed a set of 241
skipped exons with corresponding U2-type splice sites in both species
that had no other detected AS events involving the skipped exon.
This set constituted our test set of known ACEs. Out of the 241 exons,
ﬁve were masked when applying RepeatMasker (A. Smit and P. Green,
unpublished data), showing that some classes of conserved mamma-
lian repeats can lead to conserved alternative exons. Among these
ﬁve, two were SINEs of the mammalian interspersed repeat (MIR)
type, one was an L3/CR1 LINE, one was an ERV class I LTR, and one
was a small RNA. A larger number of human skipped exons are
derived from primate-speciﬁc repetitive elements and therefore not
conserved between human and mouse [3].
In the same manner, 5,066 conserved constitutive exons in genes
exhibiting AS events elsewhere were identiﬁed. From these, we took
the 59 and 39 splice sites to train the pair splice site output
distributions in the model. For a training set for the coding states,
orthologous human/mouse coding sequences were extracted from
Ensembl, and those coding sequences annotated with start and stop
codons in both human and mouse were retained. This set consisted of
5,377 orthologous sequences with known reading frame, totaling
7,140,008 nt in human and 7,005,234 nt in mouse. For the pair states,
these sequences were aligned with BLASTN [23]. To prevent
predicted exons from including stop codons, stop codons were
removed from all coding training sequences, which effectively led to
an emission probability of zero for stop codons. Finally, a study on
the classiﬁcation of conserved functional versus nonfunctional
sequences provided alignments of 63 conserved functional non-
coding regions with a total length of 28,959 nt in human and 28,167
nt in mouse [35].
The analysis of the ENCODE target regions (http://www.ensembl.
org/Homo_sapiens/encode.html) was based on the 323 genes
located in those regions and annotated by Ensembl as reciprocal
best hit orthologs in human and mouse (Ensembl v. 22; June 2004).
Our analyses used the Ensembl gene structure annotations of these
genes. Orthologous introns were determined by concatenating the
ﬂanking 30 nt of both the upstream and downstream exons and
blasting these exon junction sequences (EJSs) against all other EJSs
from the orthologous gene. The EJS pairs were kept if the alignment
extended across the junction and included sequences from both
upstream and downstream exons. Identical EJS pairs coming from
different transcripts of the same gene were consolidated. Introns
were not considered if the intron length was smaller than 40 nt, or if
at least one of the ﬂanking exons was shorter than 30 nt. This
analysis resulted in 1,823 intron pairs, out of which 1,776 were
smaller than 30 kb in both species and subject to our analysis by
UNCOVER.
For the analysis of intron retention, we focused on intron pairs in
which each sequence was shorter than 1,000 nt, and the difference in
length did not exceed 20% of the length of the longer sequence. The
retained part together with the ﬂanking exons constitutes one large
exon, which is subject to the length restrictions observed for
mammalian exons. This is a likely reason why the few known
conserved cases of intron retention in mammals all involve relatively
short introns of less than 500 nt [19]. In addition to the ENCODE
target regions, we determined orthologous introns in the complete
human and mouse genomes as annotated by Ensembl. Of the 84,233
orthologous introns, 25,074 satisﬁed these length restrictions and
were analyzed by UNCOVER.
pHMMs: Structure, implementation, and training. HMMs provide a
probabilistic approach to a large number of problems in computa-
Table 1. Prediction Results on a Known Set of 241 Conserved Skipped Exons
Approach Number of
Predicted
Exons
(Specificity)
Number of
True Positive
Exons
(Sensitivity)
Number of
True Positives
with Both
Splice Sites
Correct
Number of
True Positives
with Only
39 Splice Site
Correct
Number of
True Positives
with Only
59 Splice Site
Correct
Total Number
of Predicted
Exonic
Nucleotides
(Specificity)
Number of
Correct
Nucleotides
(Sensitivity)
UNCOVER 309 (0.68) 210 (0.87) 129 (61%) 38 (18%) 21 (10%) 30,950 (0.72) 22,214 (0.74)
BLAST all hits 667 (0.38) 233 (0.97) 0 (0%) 0 (0%) 0 (0%) 118,685 (0.22) 26,594 (0.89)
BLAST best hit 212 (0.88) 212 (0.88) 0 (0%) 0 (0%) 0 (0%) 60,616 (0.36) 21,966 (0.74)
We compare results obtained by BLASTN analysis with those of the UNCOVER approach. Predicted regions overlapping with a known ACE in the human sequence are counted as true positives, and the fractions are given for which the
locations of the 59 splice site, the 39 splice site, or both are correct. Sensitivity is calculated as the number of true positives divided by the total number of known exons, and specificity as the number of true positives divided by the total
number of predictions. We also show the total number of nucleotides spanned by all predictions, and the number of nucleotides overlapping the known ACEs.
DOI: 10.1371/journal.pcbi.0010015.t001
SE00001084095.4:ENSG00000164402.2; terminal exons, lanes 7–9: ENSE00001379673.1:ENSG00000159140.5, ENSE00001046164.1:ENSG00000067369.1,
and ENSE00000952769.2:ENSG00000142183.3 (a known case as positive control); random negative controls, lanes 10–13: EN-
SE00001321652.4:ENSG00000161980.2, ENSE00000868377.2:ENSG00000102125.4, ENSE00001239587.1:ENSG00000100220.2, and EN-
SE00001307891.1:ENSG00000185721.1.
(B) Example UNCOVER alignment of a newly detected ACE. Aligned nucleotides are connected with a vertical dash in case of identity, a colon in case of
a transition, and a dot in case of a transversion. The alignment is labeled with the types of the states that lead to the most likely alignment: C, conserved
noncoding sequence; F, 59 splice site; I, nonconserved intronic sequence; T, 39 splice site; 1, 2, and 3, coding sequence, with the number giving the
position in a codon. The detected ACE is flanked by highly conserved noncoding sequence, a characteristic of true ACEs. The sequence shown
corresponds to the event in sample i in (A).
DOI: 10.1371/journal.pcbi.0010015.g002
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Discovering Unknown Alternative Exonstional biology, and have been applied successfully to diverse topics
ranging from gene ﬁnding to protein domain modeling [20]. A
discrete HMM contains a set of states that emit symbols from an
alphabet (here, the four nucleotides) according to a probability
distribution. The states are connected by transitions, to which
probabilities are assigned. A state in such a HMM has an associated
probability of observing each residue, and the transitions determine
the possible order of the states. A number of dynamic programming
algorithms for HMM training and application are well known. The
forward algorithm calculates the total probability that a sequence can
be generated by a model, and can be applied to classiﬁcation
problems, with several HMMs representing different classes. The
Viterbi algorithm yields the parse of a sequence with the highest
likelihood, thus assigning the symbols to model states that may
represent different functional categories such as exons and introns.
pHMMs are extensions of HMMs, originally described to perform
local or global alignments of two sequences [20]. In general, the states
of the model now contain probability distributions for an alignment
of two residues, and by using several different states, a pHMM can be
used to model different patterns of conservation. For example,
pHMM systems to identify protein-coding genes [36,37] include
different states corresponding to pairs of aligned coding and
noncoding nucleotides as well as splice sites. The standard HMM
algorithms have been generalized and described in more detail for
pHMMs [22,37] or, more generally, phylogenetic HMMs [30,38]. When
applying the pHMM Viterbi algorithm, we obtain the optimal parse
of the alignment into different functional classes along with the
alignment, based on the sequence of states used to generate the
optimal alignment.
The pHMM data structures and algorithms were implemented in
Cþþ under Linux, with classes for individual model states and the
model itself. A command-line interface allows for convenient training
of model states, assembling states into a model, and applying the
model to align two sequences. States can be either standard single
HMM states or pair states and have an associated output distribution
that may have k-order Markov dependence for a small value of k. All
single and pair output distributions in the skipped exon model were
independently estimated by maximum likelihood using datasets
described above. Pseudocounts were added to prevent likelihoods
of zero for unseen events, with the exception of the fully conserved
U2 splice site dinucleotides and the codon positions (to exclude
alignments with stop codons or substitutions of codons of amino
acids with very different properties). The Markov order of the output
distributions was usually set to one (i.e., the emission probabilities
were conditional on the previous nucleotide), with the exception of
codon states, where the conditioning was on the previous two
nucleotides. As the model topology includes many linearly connected
states with a probability of one, only few transition probabilities had
to be determined. We derived the gap parameters for functional
coding and noncoding sequences from the respective datasets, and
manually set the remaining parameters.
With N being the number of states in the model, and L the length
of one input sequence, the run time complexity of the pair Viterbi
algorithm to compute the globally best alignment is of order N
2L
2.
Thus, many applications of pHMMs, such as comparative gene
ﬁnding in mammalian genomes, where genes may span across
hundreds of kilobases or more, often have to rely on precomputed
approximate alignments as input and use the pHMM only to classify
and possibly reﬁne the alignment. For the size of most introns, it
was practically possible to use the pHMM to compute the optimal
global alignment. An optimal pairwise alignment of sequences is
usually determined by traceback through the whole dynamic
programming matrix. This requires considerable memory resources:
the space complexity is O(NL
2), growing quadratically with the
size of the input sequences, and for sequences longer than 1,000–
2,000 bp each, the forward matrix cannot be fully stored in
currently standard main memory any longer. For such sequence
pairs, we therefore switched to a divide-and-conquer version of
dynamic programming known as the Hirschberg algorithm [39],
which reduces the memory requirement to O(NL) at the cost of
doubling the run time: the Viterbi algorithm is started twice in both
directions from the beginning and end of the sequences, ﬁlling
the alignment matrix from both ends up to the center column.
During this step, only the currently computed and the previous
columns need to be kept, discarding columns computed earlier and
thus effectively reducing the memory complexity by one dimension.
The sum of the two center columns then contains the score of the
optimal alignment, and determines one state transition and pair of
Table 2. Predicted Conserved Coding IREs and Their Evidence
Category Ensembl ID Name Spliced
EST
In-Frame Size a Multiple
of Three
Protein
Domain
Known genes/EST genes/
VEGA genes
ENSE00000704494.1:ENSG00000104824.1:ENST00000221419.1 HNRPL þ  þ þ
ENSE00000795164.1:ENSG00000114416.4:ENST00000305586.3 FXR1 þþ þ þ
ENSE00000931268.1:ENSG00000138606.5:ENST00000318390.3 Q7M4L6 þþ þ  
ENSE00001200697.1:ENSG00000099783.2:ENST00000325519.2 HNRPM þþ þ þ
ENSE00001217724.2:ENSG00000105991.2:ENST00000222713.2 HOX A1 þþ    
ENSE00001303326.1:ENSG00000133107.3:ENST00000298348.2 TRPC4 þþ þ þ
ENSE00001309031.3:ENSG00000181191.2:ENST00000322083.2 PJA1 þþ þ þ
ENSE00001357671.2:ENSG00000153094.5:ENST00000337565.2 BCL2L11 þþ þ  
ENSE00001368037.1:ENSG00000162664.2:ENST00000340281.1 NM181781 þþ þ  
ENSE00001273411.1:ENSG00000176884.4:ENST00000315048.2 GRIN1  þ    
ENSE00001367814.1:ENSG00000151514.2:ENST00000339709.1 SALL3  þ þ  
New predictions ENSE00001171086.2:ENSG00000137324.1:ENST00000259865.1 BAT8 þ     
ENSE00001214119.1:ENSG00000181264.1:ENST00000314475.1 NM174926 þþ þ þ
ENSE00001376926.1:ENSG00000187999.1:ENST00000342073.1 Novel þþ þ  
ENSE00000708533.2:ENSG00000007372.5:ENST00000241001.2 PAX6   ?  þ
ENSE00000779543.1:ENSG00000078098.2:ENST00000188790.1 FAP   ?   
ENSE00000802261.1:ENSG00000118946.1:ENST00000237807.1 PCDH17  þ þ  
ENSE00000874300.2:ENSG00000108001.2:ENST00000318060.2 EBF3    þ  
ENSE00000969451.1:ENSG00000109819.1:ENST00000264867.1 PPARGC1A       
ENSE00001038178.1:ENSG00000079691.4:ENST00000259764.2 Novel   ?   
ENSE00001094545.1:ENSG00000151812.3:ENST00000281555.2 Novel   ?   
ENSE00001191057.1:ENSG00000172977.3:ENST00000308517.1 HTATIP       
ENSE00001384595.1:ENSG00000135537.4:ENST00000258002.3 LACE1       
For each candidate, the table shows Ensembl IDs of gene, transcript, and upstream exon; the HUGO gene ID (if available); whether the predicted retained intron is covered by spliced ESTs; whether it is predicted to continue in-frame with
upstream exon; whether it has a size that is a multiple of three; and whether a protein domain detected by InterPro [40] spans across it. For four genes, the frame of the upstream exon could not be uniquely determined from the human and
mouse annotations.
DOI: 10.1371/journal.pcbi.0010015.t002
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recursively to two subproblems, the alignment from the beginning
in the upper left corner to the center split point, and from the
center split point to the lower right end of the matrix, reducing the
size of the problem by half at each step, which leads to a total
doubling in run time.
To increase speed, we used the logarithm of the output and
transition probabilities, scaled by  100 and rounded to the nearest
integer to limit all operations on probabilities to sums of positive
integers. This also ensured that no over- or underﬂow of numbers
occurred. Furthermore, summations in the Viterbi matrix were not
taken over all states but only over a list of potential predecessors
(those with positive transition probabilities). This list was generated
upon loading the model, and provided considerable speedup for
sparse transition matrices. We aligned all 241 orthologous intron
pairs from the ACE set with the pHMM, ranging in size up to about
90,000 nt each. For practical reasons, we restricted the analysis of the
ENCODE region to pairs in which both sequences were smaller than
30,000 nt, setting aside 47 intron pairs longer than that.
The polypyrimidine tract upstream of the 39 splice site sometimes
appears as low-complexity sequence, as do parts of protein-coding
regions. We therefore masked only repetitive elements and not low-
complexity DNA sequences. In addition, masked sequence was
unmasked at both ends by 30 nt, to prevent functional elements
from being masked because of neighboring repeats. Repetitive
sequences are masked with strings of the letter N, which is treated
as a special unalignable character that can only be emitted from
single (but not paired) pHMM states. This effectively excludes the
possibility that any conserved sequence segments cross masked
sequence.
Experimental RT-PCR validation. Primer pairs were ﬁrst designed
to the exonic regions ﬂanking the predicted skipped exon (up to 150
nt on each side). We used the Primer3 software (http://fokker.wi.mit.
edu/primer3) with the following typical parameter settings: primer
length minimum, 18 nt, desired, 21 nt, and maximum, 24 nt; melting
temperature minimum, 55 8C, desired, 58 8C, and maximum, 61 8C;
product length, 150–250 nt; and preﬁltering of potentially misprim-
ing sequences with the provided library of human repeats. A second
round of primers included one primer placed within the predicted
ACE and one primer in either the up- or downstream exon. Primer
sequences were ordered from Invitrogen (Carlsbad, California,
United States).
PCR was carried out with the Invitrogen Taq DNA polymerase kit
on an ABI GeneAmp 9700 (Applied Biosystems, Foster City,
California, United States), with 40 cycles of separation (30 s at 94
8C), annealing (30 s at 55 8C), and extension (45 s at 72 8C). We used
BD Biosciences (San Jose, California, United States) Human MTC
Panel I normalized cDNA libraries for eight human tissues and HeLa
cell line cDNA. For the latter, ﬁrst strand cDNA synthesis was carried
out by incubating total RNA, isolated using TRIzol reagent
(Invitrogen), with an oligo(dT) primer at 65 8C for 5 min for
denaturing and then placed on ice for annealing. SuperScript III
reverse transcriptase (Invitrogen) was used for reverse transcription.
We ﬁrst tested for presence of the predicted alternative spliced exon
in brain and liver cDNA, since these tissues were reported to have the
highest levels of AS [32]. If not detected or weak, we tested for
expression in the six remaining tissues of MTC Panel I (heart,
placenta, lung, skeletal muscle, kidney, and pancreas) and in HeLa
cells.
PCR products were separated in 2% agarose gels supplemented
with ethidium bromide, DNA was visualized under a UV light, and
bands were excised and extracted for sequencing on an ABI 3730
DNA Analyzer (Applied Biosystems) using the QIAquick Gel
Extraction Kit (Qiagen, Valencia, California, United States) according
to the manufacturer’s protocol. For weak bands, we performed a
second PCR ampliﬁcation on the extracted bands as described above,
to increase the amount of DNA to levels needed for successful
sequencing.
Supporting Information
Dataset S1. Detailed Information on UNCOVER Predictions Veriﬁed
by RT-PCR or EST Evidence
Found at DOI: 10.1371/journal.pcbi.0010015.sd001 (5 KB TXT).
Dataset S2. Detailed Information on Predicted Conserved Coding
IREs
Found at DOI: 10.1371/journal.pcbi.0010015.sd002 (20 KB DOC).
Figure S1. Expression of Newly Detected Skipped Exons in Different
Human and Mouse Tissues
(A) Expression of the newly validated exons in human liver tissue and
a HeLa cell line. The sample numbering (i–vii) corresponds to the
numbers in Figure 2A; the samples, except for sample v, show
expression in brain tissue cDNA. Compared with Figure2A, it can be
seen that the inclusion of the skipped exon is tissue speciﬁc rather
than ubiquitous. Since the PCR product of sample v in Figure 2A was
carried out on HeLa cell line cDNA, the reaction shown here
(denoted with an asterisk) was carried out on brain tissue cDNA.
(B) PCR results of newly detected isoforms in other human and in
mouse tissues (see Figure 2) and validation of the orthologous mouse
exons. Roughly half of these were additionally veriﬁed by sequencing
of the mouse PCR products.
Found at DOI: 10.1371/journal.pcbi.0010015.sg001 (20 KB DOC).
Protocol S1. Detailed Information on Application and Results of the
Ka/Ks Test
Found at DOI: 10.1371/journal.pcbi.0010015.sd003 (29 KB DOC).
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The RT-PCR veriﬁed sequences described in this paper were
deposited in Genbank, under accession numbers DQ102766–
DQ102772.
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